LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo

LY303511 was developed as a negative control of LY294002 without pan‐phosphoinositide 3‐kinase (PI3K) inhibition. We hypothesize LY303511 generate reactive oxygen species (ROS) to induce apoptosis for killing oral cancer cells. In MTS assay, LY303511 dose‐responsively decreases survival in three kin...

Full description

Saved in:
Bibliographic Details
Published inEnvironmental toxicology Vol. 34; no. 8; pp. 958 - 967
Main Authors Tang, Jen‐Yang, Xu, Yi‐Hua, Lin, Li‐Ching, Ou‐Yang, Fu, Wu, Kuang‐Han, Tsao, Li‐Yi, Yu, Tzu‐Jung, Huang, Hurng‐Wern, Wang, Hui‐Ru, Liu, Wangta, Chang, Hsueh‐Wei
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.08.2019
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1520-4081
1522-7278
1522-7278
DOI10.1002/tox.22767

Cover

Loading…
Abstract LY303511 was developed as a negative control of LY294002 without pan‐phosphoinositide 3‐kinase (PI3K) inhibition. We hypothesize LY303511 generate reactive oxygen species (ROS) to induce apoptosis for killing oral cancer cells. In MTS assay, LY303511 dose‐responsively decreases survival in three kinds of oral cancer cells but little damage to normal oral cells (HGF‐1). Two oral cancer cells (CAL 27 and SCC‐9) with highly sensitivity to LY303511 were used. In 7‐aminoactinomycin D (7AAD) assay, LY303511 slightly increases subG1 population in oral cancer cells. In annexin V/7AAD and/or pancaspase assays, LY303511 induces apoptosis in oral cancer cells but HGF‐1 cells remains in basal level. In oxidative stress, LY303511 induces ROS and mitochondrial superoxide in oral cancer cells. In 8‐oxo‐2'‐deoxyguanosine assay, LY303511 induces oxidative DNA damage in oral cancer cells. In zebrafish model, LY303511 inhibits CAL 27‐xenografted tumor growth. Therefore, LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo.
AbstractList LY303511 was developed as a negative control of LY294002 without pan‐phosphoinositide 3‐kinase (PI3K) inhibition. We hypothesize LY303511 generate reactive oxygen species (ROS) to induce apoptosis for killing oral cancer cells. In MTS assay, LY303511 dose‐responsively decreases survival in three kinds of oral cancer cells but little damage to normal oral cells (HGF‐1). Two oral cancer cells (CAL 27 and SCC‐9) with highly sensitivity to LY303511 were used. In 7‐aminoactinomycin D (7AAD) assay, LY303511 slightly increases subG1 population in oral cancer cells. In annexin V/7AAD and/or pancaspase assays, LY303511 induces apoptosis in oral cancer cells but HGF‐1 cells remains in basal level. In oxidative stress, LY303511 induces ROS and mitochondrial superoxide in oral cancer cells. In 8‐oxo‐2'‐deoxyguanosine assay, LY303511 induces oxidative DNA damage in oral cancer cells. In zebrafish model, LY303511 inhibits CAL 27‐xenografted tumor growth. Therefore, LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo.
LY303511 was developed as a negative control of LY294002 without pan‐phosphoinositide 3‐kinase (PI3K) inhibition. We hypothesize LY303511 generate reactive oxygen species (ROS) to induce apoptosis for killing oral cancer cells. In MTS assay, LY303511 dose‐responsively decreases survival in three kinds of oral cancer cells but little damage to normal oral cells (HGF‐1). Two oral cancer cells (CAL 27 and SCC‐9) with highly sensitivity to LY303511 were used. In 7‐aminoactinomycin D (7AAD) assay, LY303511 slightly increases subG1 population in oral cancer cells. In annexin V/7AAD and/or pancaspase assays, LY303511 induces apoptosis in oral cancer cells but HGF‐1 cells remains in basal level. In oxidative stress, LY303511 induces ROS and mitochondrial superoxide in oral cancer cells. In 8‐oxo‐2'‐deoxyguanosine assay, LY303511 induces oxidative DNA damage in oral cancer cells. In zebrafish model, LY303511 inhibits CAL 27‐xenografted tumor growth. Therefore, LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo .
LY303511 was developed as a negative control of LY294002 without pan-phosphoinositide 3-kinase (PI3K) inhibition. We hypothesize LY303511 generate reactive oxygen species (ROS) to induce apoptosis for killing oral cancer cells. In MTS assay, LY303511 dose-responsively decreases survival in three kinds of oral cancer cells but little damage to normal oral cells (HGF-1). Two oral cancer cells (CAL 27 and SCC-9) with highly sensitivity to LY303511 were used. In 7-aminoactinomycin D (7AAD) assay, LY303511 slightly increases subG1 population in oral cancer cells. In annexin V/7AAD and/or pancaspase assays, LY303511 induces apoptosis in oral cancer cells but HGF-1 cells remains in basal level. In oxidative stress, LY303511 induces ROS and mitochondrial superoxide in oral cancer cells. In 8-oxo-2'-deoxyguanosine assay, LY303511 induces oxidative DNA damage in oral cancer cells. In zebrafish model, LY303511 inhibits CAL 27-xenografted tumor growth. Therefore, LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo.LY303511 was developed as a negative control of LY294002 without pan-phosphoinositide 3-kinase (PI3K) inhibition. We hypothesize LY303511 generate reactive oxygen species (ROS) to induce apoptosis for killing oral cancer cells. In MTS assay, LY303511 dose-responsively decreases survival in three kinds of oral cancer cells but little damage to normal oral cells (HGF-1). Two oral cancer cells (CAL 27 and SCC-9) with highly sensitivity to LY303511 were used. In 7-aminoactinomycin D (7AAD) assay, LY303511 slightly increases subG1 population in oral cancer cells. In annexin V/7AAD and/or pancaspase assays, LY303511 induces apoptosis in oral cancer cells but HGF-1 cells remains in basal level. In oxidative stress, LY303511 induces ROS and mitochondrial superoxide in oral cancer cells. In 8-oxo-2'-deoxyguanosine assay, LY303511 induces oxidative DNA damage in oral cancer cells. In zebrafish model, LY303511 inhibits CAL 27-xenografted tumor growth. Therefore, LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo.
Author Lin, Li‐Ching
Wang, Hui‐Ru
Tang, Jen‐Yang
Wu, Kuang‐Han
Yu, Tzu‐Jung
Liu, Wangta
Ou‐Yang, Fu
Huang, Hurng‐Wern
Chang, Hsueh‐Wei
Xu, Yi‐Hua
Tsao, Li‐Yi
Author_xml – sequence: 1
  givenname: Jen‐Yang
  surname: Tang
  fullname: Tang, Jen‐Yang
  organization: Kaohsiung Medical University Hospital
– sequence: 2
  givenname: Yi‐Hua
  surname: Xu
  fullname: Xu, Yi‐Hua
  organization: Kaohsiung Medical University
– sequence: 3
  givenname: Li‐Ching
  surname: Lin
  fullname: Lin, Li‐Ching
  organization: Chung Hwa University of Medical Technology
– sequence: 4
  givenname: Fu
  surname: Ou‐Yang
  fullname: Ou‐Yang, Fu
  organization: Kaohsiung Medical University Hospital
– sequence: 5
  givenname: Kuang‐Han
  surname: Wu
  fullname: Wu, Kuang‐Han
  organization: Kaohsiung Medical University
– sequence: 6
  givenname: Li‐Yi
  surname: Tsao
  fullname: Tsao, Li‐Yi
  organization: Kaohsiung Medical University
– sequence: 7
  givenname: Tzu‐Jung
  surname: Yu
  fullname: Yu, Tzu‐Jung
  organization: Kaohsiung Medical University
– sequence: 8
  givenname: Hurng‐Wern
  surname: Huang
  fullname: Huang, Hurng‐Wern
  organization: National Sun Yat‐sen University
– sequence: 9
  givenname: Hui‐Ru
  surname: Wang
  fullname: Wang, Hui‐Ru
  organization: National Sun Yat‐sen University
– sequence: 10
  givenname: Wangta
  surname: Liu
  fullname: Liu, Wangta
  email: liuwangta@kmu.edu.tw
  organization: Kaohsiung Medical University
– sequence: 11
  givenname: Hsueh‐Wei
  orcidid: 0000-0003-0068-2366
  surname: Chang
  fullname: Chang, Hsueh‐Wei
  email: changhw@kmu.edu.tw
  organization: Kaohsiung Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31115172$$D View this record in MEDLINE/PubMed
BookMark eNqNkU1rGzEQhkVIyfehf6As9JIcNpZGq489lpCmAUMuCSQQWMZabVFYS64kp_W_r2KnORgSepoPnneYmfeQ7PrgLSGfGT1nlMIkhz_nAEqqHXLABECtQOnddU7rhmq2Tw5TeqKUtlLIPbLPGWOCKTggj9MHTrlgrOpdWoy4ShX67BYxjG6wEbMLvlqEbEsTxwp_ovMpVyGWwqA3NlbGjmOqnK-eXY6hyPtN8RyOyacBx2RPXuMRuft-eXvxo57eXF1ffJvWpgGuaui1boxRFJveDKpHKXspWmbRiIYCGq2saLnFGQxqkIozNeMKGmxn5WYz8CNyuplb1v61tCl3c5de1kJvwzJ1AFpqLTTn_4FyoLptGl3Qr1voU1hGXw4pVPmy4ACyUF9eqeVsbvtuEd0c46r79-ICnG0AE0NK0Q5vCKPdi31dsa9b21fYyRZrXF57kCO68SPFbzfa1fuju9ub-43iL6maqdk
CitedBy_id crossref_primary_10_1016_j_intimp_2023_109997
crossref_primary_10_3390_ijms241512079
crossref_primary_10_3390_cancers13102450
crossref_primary_10_3389_fmed_2022_875517
crossref_primary_10_3390_antiox9111120
crossref_primary_10_3390_antiox9090876
Cites_doi 10.1186/1756-9966-29-34
10.2741/s465
10.1016/j.fct.2013.07.012
10.1016/j.archoralbio.2016.02.019
10.1016/S0014-5793(04)00058-4
10.2147/OTT.S138123
10.1002/tox.22625
10.1016/S0021-9258(17)37680-9
10.1016/j.semcdb.2017.05.023
10.1124/jpet.105.083550
10.1002/tox.22516
10.1016/j.cell.2017.07.029
10.1016/j.ctrv.2017.07.005
10.1158/0008-5472.CAN-05-0152
10.1089/dna.2015.3044
10.3390/molecules23040849
10.1016/j.bbrc.2008.09.094
10.1016/j.bcp.2012.08.028
10.3390/molecules170910916
10.1016/j.bcp.2011.09.025
10.1002/tox.22588
10.1016/j.advenzreg.2008.04.002
10.1016/j.bbrc.2007.04.106
10.3389/fphys.2017.00634
10.1111/fcp.12043
10.1177/00220345940730080301
10.1158/0008-5472.CAN-08-1996
10.1371/journal.pone.0068425
10.1155/2015/294303
10.1021/jf103488j
10.1002/tox.22629
10.1038/sj.cdd.4402177
10.1074/jbc.270.19.11684
10.1016/j.freeradbiomed.2009.12.022
10.1016/j.ceb.2017.02.007
10.1002/j.1460-2075.1996.tb00911.x
10.18632/oncotarget.5414
10.1016/j.ctrv.2008.07.004
10.1038/nrd2803
ContentType Journal Article
Copyright 2019 Wiley Periodicals, Inc.
Copyright_xml – notice: 2019 Wiley Periodicals, Inc.
DBID AAYXX
CITATION
NPM
7QH
7ST
7TN
7U7
7UA
C1K
F1W
H97
K9.
L.G
M7N
SOI
7X8
7S9
L.6
DOI 10.1002/tox.22767
DatabaseName CrossRef
PubMed
Aqualine
Environment Abstracts
Oceanic Abstracts
Toxicology Abstracts
Water Resources Abstracts
Environmental Sciences and Pollution Management
ASFA: Aquatic Sciences and Fisheries Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
ProQuest Health & Medical Complete (Alumni)
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Algology Mycology and Protozoology Abstracts (Microbiology C)
Environment Abstracts
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
PubMed
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Oceanic Abstracts
Toxicology Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
ASFA: Aquatic Sciences and Fisheries Abstracts
ProQuest Health & Medical Complete (Alumni)
Aqualine
Environment Abstracts
Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality
Water Resources Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
PubMed
CrossRef
AGRICOLA
MEDLINE - Academic
Aquatic Science & Fisheries Abstracts (ASFA) Professional
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Ecology
Oceanography
EISSN 1522-7278
EndPage 967
ExternalDocumentID 31115172
10_1002_tox_22767
TOX22767
Genre article
Journal Article
GrantInformation_xml – fundername: Ministry of Science and Technology, Taiwan
  funderid: MOST 107‐2314‐B‐037‐048; MOST 107‐2314‐B‐037‐057; MOST 107‐2320‐B‐037‐016; MOST 107‐2628‐B‐037‐001; MOST107‐2311‐B‐037‐001
– fundername: Health and Welfare Surcharge of Tobacco Products
– fundername: Ministry of Science and Technology
– fundername: Kaohsiung Medical University
– fundername: National Sun Yat‐sen University‐KMU Joint Research Project
  funderid: #NSYSUKMU 108‐P001; NSYSUKMU 108‐P001
– fundername: ChangHua Christian Hospital‐KMU Fund
  funderid: 108‐CCH‐KMU‐008
– fundername: Health and Welfare Surcharge of Tobacco Products, the Ministry of Health and Welfare, Taiwan, Republic of China
  funderid: MOHW108‐TDU‐B‐212‐124016
– fundername: Ministry of Health and Welfare, Taiwan, Republic of China
– fundername: Kaohsiung Medical University Hospital
  funderid: KMUH105‐5M24; KMUH107‐7R74
– fundername: Health and Welfare Surcharge of Tobacco Products, the Ministry of Health and Welfare, Taiwan, Republic of China
  grantid: MOHW108-TDU-B-212-124016
– fundername: Kaohsiung Medical University Hospital
  grantid: KMUH105-5M24
– fundername: National Sun Yat-sen University-KMU Joint Research Project
  grantid: #NSYSUKMU 108-P001
– fundername: Ministry of Science and Technology, Taiwan
  grantid: MOST 107-2320-B-037-016
– fundername: Ministry of Science and Technology, Taiwan
  grantid: MOST107-2311-B-037-001
– fundername: Kaohsiung Medical University Hospital
  grantid: KMUH107-7R74
– fundername: Ministry of Science and Technology, Taiwan
  grantid: MOST 107-2314-B-037-048
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OC
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHBH
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AI.
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
GWYGA
H.T
H.X
HF~
HGLYW
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
RYL
SUPJJ
SV3
UB1
V2E
VH1
W8V
W99
WBKPD
WIH
WIK
WOHZO
WQJ
WRC
WUPDE
WXSBR
WYISQ
XG1
XPP
XV2
~IA
~KM
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
1OB
7QH
7ST
7TN
7U7
7UA
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
C1K
F1W
H97
K9.
L.G
M7N
SOI
7X8
7S9
L.6
ID FETCH-LOGICAL-c4237-2d884cc70a4dcf7da66d6591eac5402ac87e593eab2f7f67317b3724a9b767cf3
IEDL.DBID DR2
ISSN 1520-4081
1522-7278
IngestDate Fri Jul 11 18:24:19 EDT 2025
Thu Jul 10 18:47:48 EDT 2025
Wed Aug 13 03:08:52 EDT 2025
Thu Apr 03 06:56:17 EDT 2025
Tue Jul 01 01:50:04 EDT 2025
Thu Apr 24 23:01:33 EDT 2025
Wed Jan 22 16:39:49 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords LY303511
preferential killing
oral cancer
oxidative stress
zebrafish xenograft model
Language English
License 2019 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4237-2d884cc70a4dcf7da66d6591eac5402ac87e593eab2f7f67317b3724a9b767cf3
Notes Funding information
Health and Welfare Surcharge of Tobacco Products, the Ministry of Health and Welfare, Taiwan, Republic of China, Grant/Award Number: MOHW108‐TDU‐B‐212‐124016; Kaohsiung Medical University Hospital, Grant/Award Numbers: KMUH105‐5M24, KMUH107‐7R74; Ministry of Science and Technology, Taiwan, Grant/Award Numbers: MOST 107‐2314‐B‐037‐048, MOST 107‐2314‐B‐037‐057, MOST 107‐2320‐B‐037‐016, MOST 107‐2628‐B‐037‐001, MOST107‐2311‐B‐037‐001; National Sun Yat‐sen University‐KMU Joint Research Project, Grant/Award Numbers: #NSYSUKMU 108‐P001, NSYSUKMU 108‐P001; Ministry of Health and Welfare, Taiwan, Republic of China; Health and Welfare Surcharge of Tobacco Products; ChangHua Christian Hospital‐KMU Fund, Grant/Award Number: 108‐CCH‐KMU‐008; Kaohsiung Medical University; Ministry of Science and Technology
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0068-2366
PMID 31115172
PQID 2252253226
PQPubID 866374
PageCount 10
ParticipantIDs proquest_miscellaneous_2286885833
proquest_miscellaneous_2232089448
proquest_journals_2252253226
pubmed_primary_31115172
crossref_primary_10_1002_tox_22767
crossref_citationtrail_10_1002_tox_22767
wiley_primary_10_1002_tox_22767_TOX22767
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2019
PublicationDateYYYYMMDD 2019-08-01
PublicationDate_xml – month: 08
  year: 2019
  text: August 2019
PublicationDecade 2010
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Hoboken
PublicationTitle Environmental toxicology
PublicationTitleAlternate Environ Toxicol
PublicationYear 2019
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2012; 83
2009; 69
2017; 8
2015; 6
2000; 6
2005; 314
2017; 45
2017; 170
2018; 80
2005; 65
2012; 17
2011; 59
2014; 28
2018; 23
2013; 8
1996; 15
1995; 270
2007; 14
2016; 35
2009; 35
2013; 59
2010; 48
2007; 358
1994; 269
2017; 59
2010; 29
2017; 10
2015; 2015
2008; 48
2009; 8
2008; 377
2004; 559
2018; 33
2016; 8
1994; 73
2012; 84
2016; 66
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_14_1
e_1_2_7_13_1
e_1_2_7_12_1
e_1_2_7_11_1
e_1_2_7_10_1
e_1_2_7_26_1
e_1_2_7_27_1
e_1_2_7_28_1
e_1_2_7_29_1
e_1_2_7_30_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_23_1
e_1_2_7_33_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_37_1
e_1_2_7_38_1
e_1_2_7_39_1
Hu L (e_1_2_7_2_1) 2000; 6
References_xml – volume: 377
  start-page: 187
  issue: 1
  year: 2008
  end-page: 190
  article-title: LY294002 inhibits leukemia cell invasion and migration through early growth response gene 1 induction independent of phosphatidylinositol 3‐kinase‐Akt pathway
  publication-title: Biochem Biophys Res Commun
– volume: 59
  start-page: 2284
  issue: 6
  year: 2011
  end-page: 2290
  article-title: (−)‐Anonaine induces DNA damage and inhibits growth and migration of human lung carcinoma h1299 cells
  publication-title: J Agric Food Chem
– volume: 48
  start-page: 179
  year: 2008
  end-page: 187
  article-title: Protein kinase CK2‐‐a key suppressor of apoptosis
  publication-title: Adv Enzyme Regul
– volume: 80
  start-page: 50
  year: 2018
  end-page: 64
  article-title: ROS signalling in the biology of cancer
  publication-title: Semin Cell Dev Biol
– volume: 8
  start-page: 579
  issue: 7
  year: 2009
  end-page: 591
  article-title: Targeting cancer cells by ROS‐mediated mechanisms: a radical therapeutic approach?
  publication-title: Nat Rev Drug Discov
– volume: 48
  start-page: 749
  issue: 6
  year: 2010
  end-page: 762
  article-title: Reactive oxygen species, cellular redox systems, and apoptosis
  publication-title: Free Radic Biol Med
– volume: 59
  start-page: 657
  year: 2013
  end-page: 669
  article-title: Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactive oxygen species: a potential new drug for treatment of glioblastoma multiforme
  publication-title: Food Chem Toxicol
– volume: 14
  start-page: 1813
  issue: 10
  year: 2007
  end-page: 1825
  article-title: LY303511 amplifies TRAIL‐induced apoptosis in tumor cells by enhancing DR5 oligomerization, DISC assembly, and mitochondrial permeabilization
  publication-title: Cell Death Differ
– volume: 17
  start-page: 10916
  issue: 9
  year: 2012
  end-page: 10927
  article-title: Antiproliferation and induction of apoptosis in Ca9‐22 oral cancer cells by ethanolic extract of
  publication-title: Molecules
– volume: 35
  start-page: 210
  issue: 5
  year: 2016
  end-page: 216
  article-title: Butanol‐partitioned extraction from aqueous extract of inhibits cell proliferation of oral cancer cells involving apoptosis and oxidative stress
  publication-title: DNA Cell Biol
– volume: 6
  start-page: 34859
  issue: 33
  year: 2015
  end-page: 34874
  article-title: Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway
  publication-title: Oncotarget
– volume: 559
  start-page: 141
  issue: 1–3
  year: 2004
  end-page: 144
  article-title: LY294002 inhibits monocyte chemoattractant protein‐1 expression through a phosphatidylinositol 3‐kinase‐independent mechanism
  publication-title: FEBS Lett
– volume: 314
  start-page: 1134
  issue: 3
  year: 2005
  end-page: 1143
  article-title: LY303511 (2‐piperazinyl‐8‐phenyl‐4H‐1‐benzopyran‐4‐one) acts via phosphatidylinositol 3‐kinase‐independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)‐ and non‐mTOR‐dependent mechanisms
  publication-title: J Pharmacol Exp Ther
– volume: 65
  start-page: 6264
  issue: 14
  year: 2005
  end-page: 6274
  article-title: LY294002 and LY303511 sensitize tumor cells to drug‐induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3‐kinase‐Akt pathway
  publication-title: Cancer Res
– volume: 8
  issue: 7
  year: 2013
  article-title: Flow cytometric quantification of all phases of the cell cycle and apoptosis in a two‐color fluorescence plot
  publication-title: PLoS One
– volume: 358
  start-page: 203
  issue: 1
  year: 2007
  end-page: 208
  article-title: Simple quantitative detection of mitochondrial superoxide production in live cells
  publication-title: Biochem Biophys Res Commun
– volume: 45
  start-page: 62
  year: 2017
  end-page: 71
  article-title: PI3K signaling in cancer: beyond AKT
  publication-title: Curr Opin Cell Biol
– volume: 29
  start-page: 34
  year: 2010
  article-title: Phosphatidylinositol 3‐kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo
  publication-title: J Exp Clin Cancer Res
– volume: 10
  start-page: 3289
  year: 2017
  end-page: 3297
  article-title: Reactive oxygen species mediate soft corals‐derived sinuleptolide‐induced antiproliferation and DNA damage in oral cancer cells
  publication-title: Onco Targets Ther
– volume: 35
  start-page: 32
  issue: 1
  year: 2009
  end-page: 46
  article-title: Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
  publication-title: Cancer Treat Rev
– volume: 69
  start-page: 1941
  issue: 5
  year: 2009
  end-page: 1950
  article-title: LY303511 enhances TRAIL sensitivity of SHEP‐1 neuroblastoma cells via hydrogen peroxide‐mediated mitogen‐activated protein kinase activation and up‐regulation of death receptors
  publication-title: Cancer Res
– volume: 73
  start-page: 1407
  issue: 8
  year: 1994
  end-page: 1415
  article-title: Regulation of PG synthase by EGF and PDGF in human oral, breast, stomach, and fibrosarcoma cancer cell lines
  publication-title: J Dent Res
– volume: 33
  start-page: 1029
  issue: 10
  year: 2018
  end-page: 1038
  article-title: CYP450‐mediated mitochondrial ROS production involved in arecoline N‐oxide‐induced oxidative damage in liver cell lines
  publication-title: Environ Toxicol
– volume: 33
  start-page: 1229
  year: 2018
  end-page: 1236
  article-title: Chemical evaluation and cytotoxic mechanism investigation of extract in lymphoma SUP‐T1 cells
  publication-title: Environ Toxicol
– volume: 6
  start-page: 880
  issue: 3
  year: 2000
  end-page: 886
  article-title: In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3‐kinase inhibitor (LY294002)
  publication-title: Clin Cancer Res
– volume: 28
  start-page: 414
  issue: 4
  year: 2014
  end-page: 422
  article-title: Phosphatidylinositol 3‐kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines
  publication-title: Fundam Clin Pharmacol
– volume: 33
  start-page: 295
  issue: 3
  year: 2018
  end-page: 304
  article-title: 4beta‐Hydroxywithanolide E selectively induces oxidative DNA damage for selective killing of oral cancer cells
  publication-title: Environ Toxicol
– volume: 23
  start-page: 849
  issue: 4
  year: 2018
  article-title: Sinularin selectively kills breast cancer cells showing G2/M arrest, apoptosis, and oxidative DNA damage
  publication-title: Molecules
– volume: 170
  start-page: 605
  issue: 4
  year: 2017
  end-page: 635
  article-title: The PI3K pathway in human disease
  publication-title: Cell
– volume: 59
  start-page: 93
  year: 2017
  end-page: 101
  article-title: Phosphoinositide 3‐kinase (PI3K) pathway inhibitors in solid tumors: from laboratory to patients
  publication-title: Cancer Treat Rev
– volume: 15
  start-page: 5256
  issue: 19
  year: 1996
  end-page: 5267
  article-title: Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002
  publication-title: EMBO J
– volume: 84
  start-page: 1307
  issue: 10
  year: 2012
  end-page: 1317
  article-title: Reactive oxygen species (ROS) and sensitization to TRAIL‐induced apoptosis, in Bayesian network modelling of HeLa cell response to LY303511
  publication-title: Biochem Pharmacol
– volume: 270
  start-page: 11684
  issue: 19
  year: 1995
  end-page: 11691
  article-title: Antagonists of phosphatidylinositol 3‐kinase block activation of several novel protein kinases in neutrophils
  publication-title: J Biol Chem
– volume: 8
  start-page: 312
  year: 2016
  end-page: 320
  article-title: Role of mitochondria, ROS, and DNA damage in arsenic induced carcinogenesis
  publication-title: Front Biosci
– volume: 2015
  start-page: 294303
  year: 2015
  article-title: Increased oxidative stress as a selective anticancer therapy
  publication-title: Oxid Med Cell Longev
– volume: 83
  start-page: 106
  issue: 1
  year: 2012
  end-page: 114
  article-title: The phosphatidylinositol 3‐kinase (PI3K) inhibitor LY294002 modulates cytokine expression in macrophages via p50 nuclear factor kappaB inhibition, in a PI3K‐independent mechanism
  publication-title: Biochem Pharmacol
– volume: 66
  start-page: 147
  year: 2016
  end-page: 154
  article-title: Sinuleptolide inhibits proliferation of oral cancer Ca9‐22 cells involving apoptosis, oxidative stress, and DNA damage
  publication-title: Arch Oral Biol
– volume: 269
  start-page: 5241
  issue: 7
  year: 1994
  end-page: 5248
  article-title: A specific inhibitor of phosphatidylinositol 3‐kinase, 2‐(4‐morpholinyl)‐8‐phenyl‐4H‐1‐benzopyran‐4‐one (LY294002)
  publication-title: J Biol Chem
– volume: 8
  start-page: 634
  year: 2017
  article-title: Withaferin A induces oxidative stress‐mediated apoptosis and DNA damage in oral cancer cells
  publication-title: Front Physiol
– volume: 33
  start-page: 1195
  issue: 11
  year: 2018
  end-page: 1203
  article-title: A novel sulfonyl chromen‐4‐ones (CHW09) preferentially kills oral cancer cells showing apoptosis, oxidative stress, and DNA damage
  publication-title: Environ Toxicol
– ident: e_1_2_7_10_1
  doi: 10.1186/1756-9966-29-34
– volume: 6
  start-page: 880
  issue: 3
  year: 2000
  ident: e_1_2_7_2_1
  article-title: In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3‐kinase inhibitor (LY294002)
  publication-title: Clin Cancer Res
– ident: e_1_2_7_35_1
  doi: 10.2741/s465
– ident: e_1_2_7_40_1
  doi: 10.1016/j.fct.2013.07.012
– ident: e_1_2_7_20_1
  doi: 10.1016/j.archoralbio.2016.02.019
– ident: e_1_2_7_11_1
  doi: 10.1016/S0014-5793(04)00058-4
– ident: e_1_2_7_28_1
  doi: 10.2147/OTT.S138123
– ident: e_1_2_7_37_1
  doi: 10.1002/tox.22625
– ident: e_1_2_7_8_1
  doi: 10.1016/S0021-9258(17)37680-9
– ident: e_1_2_7_18_1
  doi: 10.1016/j.semcdb.2017.05.023
– ident: e_1_2_7_12_1
  doi: 10.1124/jpet.105.083550
– ident: e_1_2_7_29_1
  doi: 10.1002/tox.22516
– ident: e_1_2_7_5_1
  doi: 10.1016/j.cell.2017.07.029
– ident: e_1_2_7_6_1
  doi: 10.1016/j.ctrv.2017.07.005
– ident: e_1_2_7_14_1
  doi: 10.1158/0008-5472.CAN-05-0152
– ident: e_1_2_7_38_1
  doi: 10.1089/dna.2015.3044
– ident: e_1_2_7_23_1
  doi: 10.3390/molecules23040849
– ident: e_1_2_7_32_1
  doi: 10.1016/j.bbrc.2008.09.094
– ident: e_1_2_7_15_1
  doi: 10.1016/j.bcp.2012.08.028
– ident: e_1_2_7_21_1
  doi: 10.3390/molecules170910916
– ident: e_1_2_7_34_1
  doi: 10.1016/j.bcp.2011.09.025
– ident: e_1_2_7_25_1
  doi: 10.1002/tox.22588
– ident: e_1_2_7_41_1
  doi: 10.1016/j.advenzreg.2008.04.002
– ident: e_1_2_7_27_1
  doi: 10.1016/j.bbrc.2007.04.106
– ident: e_1_2_7_24_1
  doi: 10.3389/fphys.2017.00634
– ident: e_1_2_7_9_1
  doi: 10.1111/fcp.12043
– ident: e_1_2_7_19_1
  doi: 10.1177/00220345940730080301
– ident: e_1_2_7_13_1
  doi: 10.1158/0008-5472.CAN-08-1996
– ident: e_1_2_7_22_1
  doi: 10.1371/journal.pone.0068425
– ident: e_1_2_7_16_1
  doi: 10.1155/2015/294303
– ident: e_1_2_7_39_1
  doi: 10.1021/jf103488j
– ident: e_1_2_7_26_1
  doi: 10.1002/tox.22629
– ident: e_1_2_7_31_1
  doi: 10.1038/sj.cdd.4402177
– ident: e_1_2_7_30_1
  doi: 10.1074/jbc.270.19.11684
– ident: e_1_2_7_36_1
  doi: 10.1016/j.freeradbiomed.2009.12.022
– ident: e_1_2_7_4_1
  doi: 10.1016/j.ceb.2017.02.007
– ident: e_1_2_7_7_1
  doi: 10.1002/j.1460-2075.1996.tb00911.x
– ident: e_1_2_7_3_1
  doi: 10.18632/oncotarget.5414
– ident: e_1_2_7_17_1
  doi: 10.1016/j.ctrv.2008.07.004
– ident: e_1_2_7_33_1
  doi: 10.1038/nrd2803
SSID ssj0009656
Score 2.2561352
Snippet LY303511 was developed as a negative control of LY294002 without pan‐phosphoinositide 3‐kinase (PI3K) inhibition. We hypothesize LY303511 generate reactive...
LY303511 was developed as a negative control of LY294002 without pan-phosphoinositide 3-kinase (PI3K) inhibition. We hypothesize LY303511 generate reactive...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 958
SubjectTerms 1-Phosphatidylinositol 3-kinase
8-Hydroxydeoxyguanosine
Annexin V
Apoptosis
Assaying
Cancer
Cells
Danio rerio
Displays
DNA
DNA damage
Freshwater fishes
Health risk assessment
Kinases
LY303511
Mitochondria
mouth neoplasms
neoplasm cells
Neoplasms
Oral cancer
Oxidative stress
phosphatidylinositol 3-kinase
preferential killing
Reactive oxygen species
Superoxide
Survival
Xenografts
Zebrafish
zebrafish xenograft model
Title LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Ftox.22767
https://www.ncbi.nlm.nih.gov/pubmed/31115172
https://www.proquest.com/docview/2252253226
https://www.proquest.com/docview/2232089448
https://www.proquest.com/docview/2286885833
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9UwFD-MwUAEdfPr6pQoPvjSuzZt0wSfRDaGqAPZ4AqDkq-O4mgvt73D-dfvJGk75lTEt7Y5Kfk4J-eX9pxfAN6YWKiUZTJKlFZRVkiD66BII6MS9xEyY7l1icKfv7DDk-zjIl9swLsxFybwQ0wf3Jxl-PXaGbhU3d41aWjf_phTWjCXSe5itRwg-npNHSWYP7kV3VOMeySejKxCMd2bat70RbcA5k286h3OwX04HZsa4ky-z9e9muufv7A4_mdfHsC9AYiS90FztmHDNjuwte9JrC934O6RtrIZ-Kwfwumnb6n_G0hM3S3P5WVHcErqpTvzp7JBi8iy7V3sEb5VnskacSdx6f9EO8VaEfeLoCN1Qy7qftVidRNuLtpHcHKwf_zhMBoOZoi0i6KJqOE807qIZWZ0VRjJmGG5SHARRwBIpeaFzUVqpaJVUbECMYpKC5pJobCPukofw2bTNvYpEHxemcrmVMYm4wKdZZ6b2NDYcI2vSmbwdpyiUg-s5e7wjPMy8C3TEseu9GM3g9eT6DJQdfxOaHec53Kw1g5LEIXmuLSxGbyaitHO3MjIxrZrJ5PSmAvczf5NhjPOXR7bDJ4EHZpakqJTyREtYoe8Jvy5ieXx0cJfPPt30edwB5GcCJGJu7DZr9b2BaKlXr30ZnEF6YEPpg
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3pa9RAFH_UiiiCR71Wq47iB79km0ySOcAvoi2rbluQLaxQCXNFgiVZdrPF-tf7JlepF-K3JPMmzPHevN9cvwfwwoZSxyxRQaSNDhKuLI6DMg6sjvwiZMJS5y8K7x-wyVHyfp7ON-BVfxem5YcYFty8ZTTjtTdwvyC9c84aWlffxpRyxi_BZR_R28cvePvxnDxKsiZ2KzqoEGdJIup5hUK6M2S96I1-gZgXEWvjcvZuwue-sO1Jk6_jda3H5vtPPI7_W5tbcKPDouR1qzy3YcOVW3Blt-GxPtuC64fGqbKjtL4Dx9NPcbMhSGyxWpyosxXBXikWPuxP7lpFIouq9seP8K_qiyoQehLPAECM160l8bsEK1KU5LSolxVmt-3LaXUXjvZ2Z28mQRebITD-IE1ArRCJMTxUiTU5t4oxy1IZ4TiOGJAqI7hLZeyUpjnPGUeYomNOEyU11tHk8T3YLKvSPQCC33Obu5Sq0CZCor9MUxtaGlph8FfRCF72fZSZjrjcx884yVrKZZph22VN243g-SC6aNk6fie03Xd01hnsClMQiKY4urERPBuS0dR8y6jSVWsvE9NQSJzQ_k1GMCH8VbYR3G-VaChJjH4lRcCIFWpU4c9FzGaH8-bh4b-LPoWrk9n-NJu-O_jwCK4hsJPtQcVt2KyXa_cYwVOtnzQ28gPQhBPA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwEB6VIhBC4ijXQgGDeOAl28RJHFs8IeiqQGkRaqWtVCnyFRRRJdFutqL8esbOUZVLiLckHkc-Zjyfj_kM8MKEQsUskUGktAqSTBocB0UcGBW5RciEpdYFCn_cYzuHyft5Ol-DV0MsTMcPMS64Ocvw47Uz8MYUW-ekoW39bUppxrJLcDlhaCwOEX0-544SzF_div4pxEkSjwZaoZBujVkvOqNfEOZFwOo9zuwmHA9l7Q6afJ2uWjXV33-icfzPytyCGz0SJa871bkNa7bagCvbnsX6bAOu72srq57Q-g4c7x7FfjuQmHLZnMizJcE-KRt36U9hOzUiTd26w0f4V_lFlgg8iYv_J9pp1oK4PYIlKStyWraLGrOb7uW0vguHs-2DNztBfzNDoN0xmoAazhOts1AmRheZkYwZlooIR3FEgFRqntlUxFYqWmQFyxCkqDijiRQK66iL-B6sV3VlHwDB74UpbEplaBIu0FumqQkNDQ3X-KtoAi-HLsp1T1vubs84yTvCZZpj2-W-7SbwfBRtOq6O3wltDv2c9-a6xBSEoSmObWwCz8ZkNDTXMrKy9crJxDTkAqezf5PhjHMXyDaB-50OjSWJ0aukCBexQl4T_lzE_GB_7h8e_rvoU7j66e0s33239-ERXENUJ7pTipuw3i5W9jEip1Y98RbyA6S4Eng
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LY303511+displays+antiproliferation+potential+against+oral+cancer+cells+in+vitro+and+in+vivo&rft.jtitle=Environmental+toxicology&rft.au=Tang%2C+Jen-Yang&rft.au=Xu%2C+Yi-Hua&rft.au=Lin%2C+Li-Ching&rft.au=Ou-Yang%2C+Fu&rft.date=2019-08-01&rft.eissn=1522-7278&rft_id=info:doi/10.1002%2Ftox.22767&rft_id=info%3Apmid%2F31115172&rft.externalDocID=31115172
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1520-4081&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1520-4081&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1520-4081&client=summon